All times are listed in CEST (Central European Summer Time)

Browsing Over 275 Presentations

Sort By
Industry Satellite Symposium

Addressing resistance to checkpoint inhibitors in NSCLC (ID 3)

Lecture Time
11:55 - 12:15
Speakers
  • Federico Cappuzzo (Rome, Italy)
Session Name
Mirati Therapeutics, Inc. - Tailoring therapy: Emerging treatment options in NSCLC
Location
Forum Hall, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Industry Satellite Symposium

The turning point: Practical considerations when emerging biomarkers become actionable (ID 17)

Lecture Time
11:50 - 12:05
Speakers
  • Keith Kerr (Aberdeen, United Kingdom)
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Industry Satellite Symposium

Targeting KRAS-driven NSCLC (ID 4)

Lecture Time
12:15 - 12:35
Speakers
  • Martin Reck (Grosshansdorf, Germany)
Session Name
Mirati Therapeutics, Inc. - Tailoring therapy: Emerging treatment options in NSCLC
Location
Forum Hall, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Industry Satellite Symposium

Forward thinking: Future perspectives in targeting KRAS in NSCLC (ID 18)

Lecture Time
12:05 - 12:20
Speakers
  • Solange Peters (Lausanne, Switzerland)
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Industry Satellite Symposium

Q&A and summary (ID 208)

Lecture Time
12:35 - 13:00
Speakers
  • All Speakers (Prague, Czech Republic)
Session Name
Mirati Therapeutics, Inc. - Tailoring therapy: Emerging treatment options in NSCLC
Location
Forum Hall, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Industry Satellite Symposium

Summary and close (ID 20)

Lecture Time
12:55 - 13:00
Speakers
  • Solange Peters (Lausanne, Switzerland)
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Industry Satellite Symposium

Audience Q&A (ID 209)

Lecture Time
12:35 - 12:55
Speakers
  • All Speakers (Prague, Czech Republic)
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Industry Satellite Symposium

Welcome and introductions (ID 1)

Lecture Time
11:30 - 11:35
Speakers
  • Martin Reck (Grosshansdorf, Germany)
Session Name
Mirati Therapeutics, Inc. - Tailoring therapy: Emerging treatment options in NSCLC
Location
Forum Hall, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Industry Satellite Symposium

Welcome and introduction (ID 15)

Lecture Time
11:30 - 11:35
Speakers
  • Solange Peters (Lausanne, Switzerland)
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Industry Satellite Symposium

Panel discussion - Managing patients with KRAS G12C-mutant NSCLC: Real-world perspectives (ID 221)

Lecture Time
12:20 - 12:35
Speakers
  • All Speakers (Prague, Czech Republic)
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Industry Satellite Symposium

The evolving landscape of advanced NSCLC therapy (ID 2)

Lecture Time
11:35 - 11:55
Speakers
  • Rosalyn Juergens (Hamilton, ON, Canada)
Session Name
Mirati Therapeutics, Inc. - Tailoring therapy: Emerging treatment options in NSCLC
Location
Forum Hall, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00
Industry Satellite Symposium

KRASG12C inhibition: A major landmark in 2nd line treatment of patients with advanced NSCLC (ID 16)

Lecture Time
11:35 - 11:50
Speakers
  • Joop De Langen (Amsterdam, Netherlands)
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00